InvestorsHub Logo
Followers 36
Posts 10734
Boards Moderated 0
Alias Born 05/03/2010

Re: None

Monday, 08/07/2023 8:33:54 AM

Monday, August 07, 2023 8:33:54 AM

Post# of 42553
News!!

Humanigen Announces First Participant Dosed in RATinG Trial of Lenzilumab for Early Treatment of Acute Graft Versus Host Disease Following Allogeneic Stem Cell Transplantation

https://www.newsfilecorp.com/release/176234/